e-learning
resources
Munich 2006
Tuesday 05.09.2006
Implications of progressive airway obstruction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients
V. K. Gavrisyuk, N. I. Gumenyuk, Y. A. Dzyublik, N. D. Morskaya (Kiev, Ukraine)
Source:
Annual Congress 2006 - Implications of progressive airway obstruction
Session:
Implications of progressive airway obstruction
Session type:
Poster Discussion
Number:
3667
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. K. Gavrisyuk, N. I. Gumenyuk, Y. A. Dzyublik, N. D. Morskaya (Kiev, Ukraine). Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients. Eur Respir J 2006; 28: Suppl. 50, 3667
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Erythropoietin in chronic obstructive pulmonary disease patients without anemia
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003
Targeted therapy in eosinophilic chronic obstructive pulmonary disease
Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020
Year: 2021
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Metabolic syndrome in chronic obstructive pulmonary disease
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Chronic pain in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Bronchodilators in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266
Year: 2006
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept